Pathology Doctors in Smithtown, NY Accepting Medicare

3 Pathology doctors found. Showing 1 - 3

Dr. Steve A Mcclain, M.D, Pathology - Dermatopathology Medicare: Not Enrolled in Medicare Practice Location: 45 Manor Rd, Smithtown, NY 11787 Phone: 631-361-4000    Fax: 631-361-4037

Dr. Shelley L Tepper, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 45 Manor Rd, Smithtown, NY 11787 Phone: 631-361-4000    Fax: 631-361-4037

Dr. Alan B Macdonald, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 50 Route 25a, Smithtown, NY 11787 Phone: 631-862-3064    Fax: 631-862-3863

News Archive

Eddingpharm Secures Immutep's Immufact IMP321 For Growing Stable

Eddingpharm continued to aggressively build its product portfolio by inking another cancer agreement, this time with Immutep. In this latest agreement, Eddingpharm was granted exclusive rights to develop and market ImmuFact® IMP321 in mainland China, Hong Kong, Macau, and Taiwan.

Octapharma sponsors symposium on inhibitors in Haemophilia A

In a showing of its continued commitment to eradicating today's major complication in the treatment of haemophilia with FVIII concentrates − i.e. anti-FVIII neutralising antibodies − Octapharma AG recently sponsored a symposium, "Inhibitors in Haemophilia A: Prevention, Current Management and Personalised Therapy Perspectives", on July 13, 2010 at the World Federation of Haemophilia's (WFH's) yearly congress.

FDA approves recombinant von Willebrand factor for treating bleeding episodes in adults with VWD

The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.

A vectored vaccine candidate against SARS-CoV-2

The current pandemic of COVID-19 is caused by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), a betacoronavirus similar to that which caused the SARS-CoV and MERS-CoV earlier. Scientists are pursuing therapeutic drugs and vaccines to counter the relentless spread of the virus, but so far, none has been established to be effective. However, several are in clinical trials in various parts of the world.

Capsule launches first intelligent touch-screen platform to manage bedside device connectivity

Capsule, the leading provider of medical device connectivity, today announced its official release of the Capsule Neuron™. Following Capsule's recent release of their Enterprise Device Connectivity Solution, the flexible, innovative Capsule Neuron platform allows the solution to be deployed across the hospital in both high and low acuity environments.

Read more Medical News

› Verified 1 days ago